Skip to main content
IPOS logo
IPOS
(NYSEARCA)
Renaissance International IPO ETF
$23.22-- (--)
Loading... - Market loading

IPOS ETF: Renaissance International IPO ETF - Price, Holdings & Analysis

Renaissance International IPO ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$23.22 - $23.33
52-Week High$26.25
52-Week Low$15.65
Open$23.33
Volume483
Average Volume (3M)2.57K
Assets (AUM)11.65M
Expense Ratio0.80%
Total Holdings52
Inception DateOct 6, 2014
1 Day Change0.44%
1 Month Change-2.49%
6 Month Change9.70%
YTD Change34.68%
1 Year Change39.47%
52-Week Change39.47%
5 Year Change-29.82%
10 Year Change18.96%
50-Day MA$23.50
200-Day MA$20.63
RSI48.81
Stochastic %K41.68
Stochastic %D23.47
Annual Dividend$0.09
Dividend Yield0.40%
Last Dividend Ex-DateJun 12, 2026
Dividend Growth YoY-46.59%
Years Dividend Growth2

Frequently Asked Questions About Renaissance International IPO ETF

What is the current price of IPOS?

The latest IPOS price is $23.22. The 52-week range is $15.65–$26.25. IPOS has returned 39.5% over the past 52 weeks.

What is the expense ratio for IPOS?

IPOS's annual expense ratio is 0.80%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does IPOS pay dividends?

Yes, IPOS pays a 0.40% dividend yield. The last ex-dividend date was 2026-06-12. View full dividend history in the Dividends section.

What are the top holdings of IPOS?

IPOS's largest holdings are Kioxia Holdings Corporation (24.3%), Kioxia Holdings Corporation (10.5%), Galderma Group AG Registered Shares (10.0%) (combined weight: 44.8%). The fund holds 52 total positions. View the complete portfolio breakdown in the Holdings section.

How does IPOS compare to similar ETFs?

Compare IPOS (0.80% expense ratio, $12M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.